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Summarv Reduced expression of E-cadherin. a Ca>-dependent cell adhesion molecule present in normal
epithelium. has been associated with invasive and metastatic cancer. Immunohistochemistry was used in
examimnng the relationship between E-cadherin expression and stage in 59 oesophageal and 52 lung cancers.
Advanced-stage oesophageal cancers were associated with both reduced and disorgam'sed E-cadhenrn expres-
sion (P<0.01). Advanced-stage lung adenocarcinomas generally exhibited disorganised or reduced E-cadherin
expression. but no statistical association between expression pattern and stage was found (P>0.05). No
differences in stage were seen between tumours With reduced or disorganised E-cadherin expression. Altered
E-cadhenin expression was detected in dysplastic. non-invasive Barrett's oesophagus. Importantly. high-level
E-cadhenrn expression was detected in 17 of 17 lymph nodes containing metastatic cancer. E-cadherin mRNA
expression was decreased in tumours with reduced protein expression. but not in tumours with disorganised
expression. Expression of ix-catenin mRNA. an E-cadherin-associated protein. was detected in tissues with
altered E-cadhenrn protein expression. Reduced and disorganised expression of E-cadherin appear to be related
to transcriptional and post-translational events respectively, and both appear to represent altered cell adhesion
associated with invasion and metastasis in thoracic neoplasms.
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Patients with oesophageal and lung cancer often have a poor
prognosis because these tumours are frequently highly
invasive or metastatic at the time of initial diagnosis. Altered
cell adhesion is a minimum requirement for cancer cells to
invade and metastasise. In order to metastasise. cells must
detach from the primary tumour. invade surrounding blood
or lymph vessels. survive in circulation and then reattach at
the metastatic site. Cell-surface adhesion molecules are likely
to be involved in both the process of detachment from
primary tumour and in reattachment at distant sites
(Takeichi. 1991). Cadherins are a family of Ca>'-dependent
cell adhesion molecules which play a major role in the tight
cell-cell associations of normal epithelial tissues (Takeichi.
1990). The x-. 3- and y-catenins are cytosolic proteins which
complex with the cadherin molecule and serve to link
cadherins to the actin cytoskeleton and other cytoplasmic
proteins (Pipenhagen and Nelson. 1993). E-cadherin is the
member of the cadhenrn superfamily which is specifically
expressed on all epithelial cells (Eidelman et al.. 1989;
Takeichi. 1990; Kemler. 1993).
Induced expression of E-cadhenrn protein has been demon-
strated to inhibit the invasive cell phenotype in vitro (Frixen
et al.. 1991; Vleminckx et al.. 1991). Non-transformed canine
kidney cells become invasive when treated with monoclonal
antibodies directed against E-cadherin or when E-cadherin
protein expression is blocked either with specific antisense
mRNA or by transforming sarcoma virus (Behrens et al..
1989: Mareel et al.. 1991). Several studies have attempted to
correlate the level of E-cadherin protein expression with the
state of differentiation. degree of invasiveness and the
presence of metastases in various human malignancies. In
primary human tumours. reduced E-cadherin protein expres-
sion has consistently been shown to be associated with a
decreased state of differentiation or increased grade of blad-
der. breast. colorectal. gastric. prostate and squamous cell
cancers of the head and neck (Umbas et al.. 1992: Bowie et
al.. 1993; Bringuier et al.. 1993: Dorudi et al.. 1993: Oka et
al.. 1993: Mayer et al.. 1993). Clear associations of E-
cadherin expression with the invasiv-e and metastatic proper-
ties of human tumours have. however. been difficult to estab-
lish. Increased invasiveness has been demonstrated in bladder
and oesophageal squamous cell cancers that exhibit decreased
E-cadherin protein expression (Bringuier et al.. 1993;
Kadowaki et al.. 1994). The presence of metastatic disease
has also been correlated with reduced E-cadherin protein
expression in breast. colorectal and oesophageal squamous
cell cancer (Dorudi et al.. 1993: Oka et al.. 1993: Kadowaki
et al.. 1994). In contrast. decreased E-cadherin protein exp-
ression was not found to be correlated with the presence of
metastases in a study of gastric cancer (Mayer et al.. 1993).
or with invasion and metastases in a study of colorectal
cancer (Kinsella et al.. 1992). Additionally. analysis of E-
cadherin protein expression in metastatic sites has yielded
contradictory results. Liver metastases from colorectal
primary tumours were found to be negative for E-cadherin
protein expression in seven of eight cases (Dorudi et al..
1993). while E-cadherin protein was expressed in six of six
liver metastases from gastric primary tumours (Mayer et al..
1993). When lymph nodes containing metastatic cells were
examined. E-cadherin protein expression was reduced in the
majority of metastatic breast and colorectal cancers (Oka et
al.. 1993; Dorudi et al.. 1993). but was preserved in lung
cancer metastases (Shimoyama et al.. 1989). E-cadherin pro-
tein expression was also reported to be increased in some
lymph nodes with foci of metastatic gastric cancer when
compared with primary tumours (Mayer et al.. 1993).
Prognosis and staging of oesophageal cancer is based
primarily on its invasiveness through the wall of the
oesophagus. while lung cancer prognosis and staging is based
on the presence of metastases to local regional lymph nodes.
To further establish the relationship between E-cadherin and
the processes of invasion and metastases. we have examined
E-cadherin protein and mRNA expression in primary
tumours and lymph node metastases of patients with either
oesophageal or lung cancer. Additionally. Barrett's oeso-
phagus was examined to study E-cadherin expression in
metaplastic and dysplastic oesophageal tissue prior to its
development into invasive cancer. The potential altered ex-
pression of ix-catenin mRNA was studied in an attempt to
identify a defect in cell adhesion in tissues with preserved
E-cadherin protein expression.
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1994Materials and methods
Human tissues
After obtaining informed consent. tissue was obtained from
patients undergoing either oesophagectomy or lung resection
for cancer, at the University of Michigan Hospital between
August 1991 and September 1993. For patients undergoing
lung resection. samples of normal lung and lung tumour were
obtained. Depending on the specific pathology of each
patient undergoing oesophagectomy. samples of normal
oesophagus. stomach. Barrett's oseophagus and oseophageal
or gastro-oesophageal junction tumours were collected.
Occasionally, portions of lymph nodes suspicious for the
presence of metastatic disease were collected when this would
not affect the staging of the patient. Immediately after resec-
tion, each tissue sample was divided into thirds. The centre
third was embedded in OCT compound (Miles, Elkhart, IN,
USA) and frozen in isopentane cooled to the temperature of
liquid nitrogen for cryostat sectioning and subsequent
immunohistochemistry. The other two portions were frozen
in liquid nitrogen for RNA isolation. Samples were then
stored at - 70'C until analysed.
[fistology and staging
The final hospital pathology reports of all patients were
reviewed and used to establish the histology and the surgical
stage of the tumours. Patients were staged according to the
AJCCS system (American Joint Committee on Cancer. 1992).
Cell lines
The human lung adenocarcinoma cell lines A549 and A427
were obtained from American Type Culture Collection
(Rockville. MD, USA) and grown in F12 Ham Kaighn's
modification (Sigma, St Louis. MO. USA) and MEM-a
(Gibco, Grand Island. NY. USA) respectively. Media were
supplemented with 10% fetal bovine serum (Gibco) and 1%
penicillin-streptomycin. Cells were washed with phosphate-
buffered saline. pelleted and stored at - 70'C for subsequent
RNA isolation. For immunohistochemistry. cells were either
cultured directly on eight-well slides or cytospun onto poly-L-
lysine-coated slides.
Immunohistochemistrv
Monoclonal antibody to E-cadherin (HECD-1) was obtained
from Zymed Laborator) (South San Francisco. CA, USA).
This antibody recognises an extracellular epitope of the E-
cadherin protein. E-cadherin protein expression was deter-
mined immunohistochemically on 5 jim cryostat sections
using a standard avidin-biotin-peroxidase complex method
as previously described (Al-Kasspooles et al.. 1993). Primary
and metastatic oesophageal. gastro-oesophageal junction and
lung cancers were examined. Additionally, specimens of Bar-
rett's oesophagus containing metaplastic and dysplastic tissue
were examined. All sections were examined by two observers
and classified as previously described (Takeichi, 1993):
(1) Preserved: intensity of staining similar to normal
epithelial tissue with well-organised cell membrane stain-
ing.
(2) Reduced: intensity of staining much reduced in com-
parison with normal tissue or absent.
(3) Disorganised variable: altered pattern of staining with
cytoplasmic expression or variable staining with some
areas preserved and other areas reduced.
Often the intensity of staining was equal to or greater than
normal tissue.
cDNA cloning
A AZAP cDNA library. constructed with 76N normal mam-
mary epithelial cell mRNA (Lee et al.. 1992). was screened
using mouse E-cadherin cDNA (Nagafuchi et al.. 1987)
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or mouse a-catenin-specific oligonucleotide (59-mer. N-
terminus) (Nagafuchi et al.. 1991). Approximately 2 x 106
recombinant phages were transferred to nitrocellulose filters
and then hybnrdised overnight at 34°C in 5 x SSC. 5 x Den-
hardt's solution, 10% SDS. 10jig ml-' polyadenylate, 100jLg
ml-' salmon sperm DNA and 50% formamide with 32P-
labelled probe. Filters were then washed sequentially at low
and high stringency. Positive plaques were purified and sub-
jected to secondary and tertiary screening. Inserts from
positive recombinants were amplified by polymerase chain
reaction (PCR) directly from phage lysates using T3 and T7
sequences as primers. The amplified inserts were labelled and
used for Southern and Northern analysis (Lee et al., 1992).
Positive clones in phages were transformed into plasmids
using the phagemid excision procedure (Stratagene, La Jolla.
CA, USA). Candidate positive clones were sequenced by the
dideoxy termination sequencing method (Sanger et al.. 1992)
with Sequenase (version 2.0; US Biochemicals). Resulting
sequences were analysed with the MacVector (IBI) sequence
analysis software.
Characterisation ofprobes
A human cx-catenin cDNA (3.7 kb). cat 11. was isolated from
a human breast epithelial cell cDNA library and partially
sequenced. The sequence of this clone is highly homologous
to the mouse ac-catenin cDNA sequence (Nagafuchi et al.,
1991) and identical to the published sequence of the human
x-catenin cDNA clone (Oda et al.. 1993). A partial E-
cadherin cDNA probe was isolated using mouse E-cadhenn
cDNA (Nagafuchi et al., 1987) as a probe. The sequence of
this E-cadherin was identical to the reported human E-
cadherin sequence (Bussmaker et al.. 1993).
Northern blot analysis
Total RNA was isolated from both tissue and cell lines using
Tn Reagent (Molecular Research Center. Cincinnati, OH.
USA) by following the manufacturer's protocol. Ten micro-
grams of total cellular RNA was separated in a 1.2% agarose
gel containing 2.2 M formaldehyde and then vacuum transfer-
red to nylon membranes (Gene Screen Plus, NEN. Wilning-
ton, DE. USA). Membranes were prehybridised in 5 x SSPE.
5 x Denhardt's. 50% formamide, 3% SDS, 5% dextran sul-
phate. 5 jg ml-' heat-denatured salmon sperm DNA and
3 jig ml-l yeast tRNA for 1 h at 48'C. Probes were labelled
with [32P}dCTP by the random primer labelling method
(Prime-It II, Stratagene. La Jolla, CA. USA) and purified by
Sephadex G-50 exclusion chromatography. Membranes were
hybridised with 1.5 x 106 c.p.m. ml-' heat-denatured, labelled
probe for 16- 18 h in a 48'C shaking water bath. Membranes
were washed according to the manufacturer's recommenda-
tions and autoradiograms prepared (Hyperfilm-MP, Amer-
sham. Arlington Heights, IL. USA). Loading and transfer of
RNA was normalised using a probe for 28S rRNA as
previously described (Hanson et al.. 1991). Autoradiographic
signals were quantified by scanning laser densitometry
(Molecular Dynamics. Sunnyvale. CA. USA).
Data analysis
There were two main objectives of the statistical analysis.
The first objective was to describe the relationship between
the pattern of E-cadherin protein expression and tumour
stage. This objective was accomplished utilising Fisher's exact
test for r x c tables (Mehta and Patel. 1983). The null
hypothesis of no association between E-cadherin expression
pattern and tumour stage was rejected at the P<0.05
significance level. The second objective was to compare
differences in tumour stages between E-cadherin protein ex-
pression patterns. This was accomplished through a pairwise
analysis of the differences between cell observed and expected
values obtained from the Fisher's exact tet for E-cadherin
expression pattern by tumour stage. All data analysis was
performed using the SAS software, release 6.07 (SAS In-
stitute. Cary. NC. USA).PFB&w*r etia
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Immohistochemistry
Normal tissues E-cadherin protein expression was examined
using immunohistochemistry in 52 lung and 43 oesophageal
adenocarcinomas to define further the relationship between
E-cadherin expression and the invasive and metastatic pro-
perties of these thoracic tumours. Expression patterns in
malignant tisues were compared with those seen in normal
lung, gastric mucosa and oesophagus (Figure la,b and d). In
normal oesophagus, E-cadherin protein is expressed cir-
cumferentially along the cell membrane of squamous
epithelial cells, although proliferating cells along the base-
ment membrane do not appear to express membrane-
assocated E-cadherin. Squamous epithelial cells lose expres-
sion of E-cadherin as they migrate towards the surface of the
mucosa prior to sloughing (not shown). Normal gastric tissue
'~~~~~eE jr"~ i - -
F~we 1 E-cadherin expression in normal, metaplas dysplastic and malignant tissue. Levels of E-cadherin expression in normal
stomach (a) normal hmg (b) (arrow indicates s E-cadherin e son at a poit ofcell-cell contact) and normal oesophagus
(d) (arrow indicates reded xpression basal layer ofsquamous epithelium) were used to define preserved E-cadherin expression.
Barrett's oesophagus with intestinal metaplasia (c) (arrow indicates goblet cells) expresses E-cadherin in a preserve fashion while
E-cdherin is disorganised to reduced in dyspiasia (B in d). Exampls of oesoph adenocarcinoma with prved (e)
disorganised (f) and reduced (g) E-cadherin of hmg adenocarcinomas with preserved (i) disorganised (j) and
reduced (k) E-adherin expression. Me atc oesopha l adoanoa (b) and metastatic lung adocacioma (1) both
express E-cadherin in a preserved fashion.also expresses abundant amounts of E-cadherin protein cir-
cumferentialy on the cell membranes of glandular epitheial
cells. In normal lung, E-cadherin protein is expressed on the
cell membranes of bronchiolar epitheial cells and at
relatively low levels at points of cell-cell contact on the
lateral borders of alveolar epithelial cells, but not along the
surface of epithelial cells facing the alveolar airspace (Figure
lb). Tbese results are consistent with previous observations
(Eidelman et al., 1989; Shimoyama et al., 1989; Kadowaki et
al., 1994).
Oesophageal and lung adenocarcinomas (Table I) Preserved
expression (E-cadherin expression similar to normal gastric
mucosa in intensity and pattern) was seen in 14% of the
oesophageal adenocarcinomas and in 23% of the lung
adenocarcinomas. Reduced to absent E-cadherin staining was
seen in 35% of the oesophageal adenocarcinomas and in
21% of the lung adenocarcinomas. Disorganised or variable
expression occurred in 51% of the oesophageal adenocar-
cinomas and in 56% of the lung adenocarcinomas. In
general, it was the well-differentiated oesophageal and lung
cancers which were observed to express E-cadherin in a
preserved fashion and the poorly differentiated tumours
which exhibited reduced or disorganised saining patterns.
Other oesophageal and gastro-oesophageal junction tunours
(Table 1) Eight specimens of oesophageal squamous cell
cancer were also examined. One specimen exhibited preserved
E-cadherin protein expression and seven specimens exhibited
either reduced or disorganised expression. Additionally, four
signet ring, one adenosquamous and one gastric cancer ofthe
gastro-oesophageal junction were examined which exhibited
reduced E-cadherin protein expression, while two gastric
cancers of the gastro-oesophageal junction exhibited disor-
gansed expression.
Fisher's exact test for r x c tables was used to examine the
relationship between tumour stage and pattern of E-cadherin
expression (Table I). No significant differences in the dis-
tribution of tumours between early and late stages were
found in tumours exhibiting disorganised or reduced E-
cadherin expression. Therefore, tumours with disorganised
and reduced staining were consided as one group of
tumours with altered stining and compared with tumours
with preserved E-cadherin expression as part of the statistical
analysis. Oesophageal adenocarcinomas demonstrated a
statistically significant association between E-cadherin expres-
sion pattern and stage, with tumours that exhibited altered
E-cadherin expression being of more advanced stage than
those which expressed E-cadherin in a preserved manner.
Lung adenocarcinomas with lymph node metastases almost
always demonstrated altered E-cadherin protein expression
but a statistically significant association between E-cadherin
expression pattern and stage was not present When all
oesophageal tumours were considered in aggregate, the high
number of squamous cell and signet ring tumours of
advanced stage with altered E-cadherin expression led to a
highly significant association between altered E-cadherin ex-
pression and advanced stage.
Lymph node metastases The most revealing tissue to
examine for E-cadherin protein expression may be sites of
metastatic disease. Local regional lymph nodes containing
metastatic oesophageal cancer (n = 12), metastatic gastric
cancer (n= 3) and metastatic lung cancer (n =2) were
examined immunohistochemically for E-cadherin protein ex-
pression (Figure lh and 1). All metastatic cells in lymph
nodes exhibited intense E-cadherin expression at levels equal
to and often greater than the primary tumour. None of the
primary tumours of these patients exhibited pres E-
cadherin expression, six had reduced expression, nine were
disorganised and two of the primary tumours were uninfor-
mative. While no metastatic sites exhibited reduced E-
cadherin protein expression, 10 of 17 lymph nodes (59%)
contained at least some metastatic cells which expressed E-
cadherin in a disorganised fashion.
E.co"h,~in vacm.'spIu.
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Table I E-cadherin protein cxpresson patterns in oesophageal and
hmg tumours
E-cadhern pattern
Stage Presed Reduced Disorganized
Oesophageal adenocarcinomas (n = 43)
I 0 0 0
Ila 2 3 3
IIb 2 1 1
III 2 5 15
IV 0 6 3
Oesophageal squanous ceUl carcinomas (n =8)
I 0 0 0
Ila 1 0 0
IIb 0 0 0
III 0 2 3
IV 0 2 0
Other oesophageal carciiomas' (n =8)
I 0 0 0
Ila 0 0 0
Hb 0 1 1
III 0 5 1
IV 0 0 0
Lung adenocarcinomas (n = 52)
I 9 6 14
II I 1 4
IIIa 2 4 10
IlIb 0 0 0
IV 0 0 1
aOthercontais foursignet rgcarcinomas, threegastrccarcinomas
of the gastro-oesophageal junction, one adenosquamous carcinoma.
Tabe H Statisfical analysis ofE-cadherin protein expression pattern
and stage
E-cadherinpattern
Stage Preserved vs alteredh P-value
AM oesophageal cancers
I 0 0'
IIa 3 (1.1) 6 (7.9)
Ilb 2 (0.5) 2 (3.5) 0.008
III 2 (3.6) 28 (26.4)
IV 0 (1.9) 16 (14.1)
Oesophageal adnocarcnormas
I 0 od
Ila 2 (1.1) 6 (6.9)
IIb 2 (0.6) 2 (3.4) 0.05
III 2 (3.1) 20 (18.9)
IV 0 (1.3) 9 (7.7)
Lung adenocarcnmas
I 9 (6.7) 20 (22.3)
II 1 (1.4) 5 (4.6)
HIa 2 (3.7) 14 (12.3) 0.55
IlIb 0 0'
IV 0 (0.2) 1 (0.8)
aAttered consists of tumours with both reduced and disorganised
eon. bNumber oftumoursobserved and, in parenthes, number
oftumowurs expected give no association betwe E-cadherin protein
expsson pattern and stage. Statisically significant association
between altered E-cadherin protein expresson and advanced stage
based on Fisher'sexact test(two-tail).'Stages inwhich noobservations
were made were not iluded n the analysis.
Barrett's oesophagus Twenty-nine specimens of Barrett's
oesophagus were examined for E-cadherin protein expression
(Figure Ic and d). Intinal, junctional and fundic types of
Barrett's metaplasia were associated with uniform, preserved
staining of high intensity without excepion. Fourteen dys-
plastic tisues exhibited a disorganised E-cadherin staining
pattern with some areas exhibiting reduced aining (Figure
Id). Staining pattems varied even within the same gland,
with dysplastic areas associated with alterd E-cadherin ex-
pression and metaplastic areas exhibiting preserved expres-
sion.E-cadherin in thoracic neoplasms
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Northern blot analysis ofE-cadherin and aE-catenin
Northern blot analysis was performed to examine the expres-
sion of E-cadhenrn mRNA in tumours and cell lines which
express E-cadherin protein in either disorganised or reduced
patterns. Lung adenocarcinomas with reduced E-cadherin
protein expression were found to express an apparently intact
E-cadherin mRNA at decreased but detectable levels (Figure
2a). Additionally. E-cadherin mRNA was nearly undetectable
in the lung adenocarcinoma cell lines A549 and A427 (Figure
2b). These cell lines expressed essentially no E-cadhenrn pro-
tein, regardless of the state of growth and confluence of the
cells in culture (not shown). Tumours with disorganised E-
a .e.o
I
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cadherin protein expression exhibited mRNA of correct size
at variable levels equal to or greater than normal tissue
(Figure 2a).
Tumours may retain preserved E-cadherin protein but
might have altered a-catenin expression which could also
contribute to defective cell adhesion and metastasis. There-
fore. the expression of a-catenin mRNA was examined by
Northern blot analysis in order to investigate this second
possible defect leading to altered tumour cell adhesion
(Figure 2b and c). Oesophageal cancers with preserved.
reduced and disorganised E-cadherin protein expression and
lymph nodes containing metastatic cancer were all found to
express a-catenin mRNA. Interestingly. a-catenin mRNA is
of correct size and expressed at high levels in both A549 and
A427 cells (Figure 2b) and in tumours with reduced and
disorganised E-cadherin expression (Figure 2c).
E-Cad
- 5.0
28S
- 4.4
b
L L T T T
Catenin
-3.8
-3.4
4.4
c
E-Cad
Catenin
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A549 A427
1 2 4 7 1 2 4 daw
5.0
- 3.8
3.4
4.4
Figure 2 a. Northern blot analysis of E-cadherin mRNA. Gas-
tric tissue (G) and normal lung (L) are used as controls for high
and low E-cadherin protein expressing tissues respectively- Lung
adenocarcinomas expressing reduced E-cadherin protein are
labelled T-red., while lung adenocarcinomas expressing disor-
ganised E-cadherin protein are labelled T-disorg. 28S rRNA is
used as a control for loading and transfer. b. Northern blot
analysis of c-catenin mRNA. Normal stomach and lung (L) are
used as controls. Lymph nodes containing metastatic oesophageal
cancer (LN-met) and primary lung adenocarcinomas (T-dis. red.
pres) express the same size mRNA transcnpts as controls. 28S
rRNA is used as a control for loading and transfer. c, Northern
blot analysis of E-cadhenrn and m-catenin mRNA in A549 and
A427 lung adenocarcinoma cells. E-cadherin protein is not detec-
table by immunohistochemistry in A549 and A427 cells. 28S
rRNA is used as a control for loading and transfer.
E-cadherin has been hypothesised to represent a likely
molecular target for altered cell adhesion in cancer. The
present study demonstrates an association between altered
E-cadherin protein expression and increased tumour stage.
although the association did not reach statistical significance
in the group of lung adenocarcinomas. Altered E-cadherin
expression appears to exist in two distinct patterns. reduced
staining and disorganised staining, although staining patterns
are somewhat heterogeneous among tumours of each pattern
and even within individual tumours. While the disorganised
pattern occurred approximately two times more frequently
than the reduced pattern. both patterns appear to identify
tumours with altered cell adhesion with a similarly increased
incidence of invasion and metastasis.
Examination of E-cadhenrn mRNA in tumours with
various E-cadhenrn protein expression patterns suggests that
there may be several possible mechanisms leading to altered
E-cadherin protein expression in these cancers. Decreased
levels of E-cadherin mRNA were seen in both primary
tumours and lung adenocarcinoma cell lines with reduced
protein expression (Figure 2a and b). This mav be consistent
with either a transcriptional down-regulation of the gene
leading to reduced or absent E-cadherin protein or actual
loss of the gene. In contrast. tumours with disorganised
protein expression were found to have E-cadherin mRNA at
similar levels and size as in normal tissue. This is consistent
with the E-cadherin protein analysis, as there is often
sigmficant immunoreactivity in these tumours. although with-
out the normal pattern that appears to be indicative of
normal cell adhesion (Figure la,b and d). The disor-
ganised protein expression present in thoracic neoplasms is
potentially related to either post-transcriptional or post-
translational events. An example of post-translational
modification of cadherin is observed during embryonic
development of the chick retina. The expression of N-
cadherin, the form of cadherin molecule expressed in neural
tissue, decreases in the developing chick retina as described
by immunoblotting (Roark et al., 1992). N-cadherin mRNA.
however, remains constant over time, a situation analogous
to that presented here in thoracic tumours with disorganised
E-cadherin protein expression. Also. in medullary thyroid
cancers E-cadherin mRNA levels remained constant while
E-cadherin protein expression was variable (Brabant et al.,
1993). In the chick retina, the extracellular portion of the
N-cadherin molecule is apparently cleaved by a metallo-
protease (Roark et al., 1992). Increased protease activity
against E-cadherin or decreased protease inhibitor activity
may account for the disorganised pattern of E-cadherin ex-
pression presented here. An altered E-cadherin protein,
potentially modified by proteolysis, was detected by Western
blot analysis in lung adenocarcinoma cells isolated from a
malignant pleural effusion (Matsuura et al., 1992). Similarly.
Western blots for E-cadherin in Barrett's metaplasia and
oesophageal adenocarcinoma revealed several bands of lowE-cadherin in hracic neoplasm
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molecular weight. possibly consistent with truncated protein
or altered glycosylation (Jankowski et al.. 1994).
Stnrkingly, all 17 lymph nodes contaiming metastatic
oesophageal. lung or gastric cancer examined in this study
had high-level, preserved. E-cadherin protein expression. Fur-
thermore. there were five tumours with preserved E-cadherin
protein expression which were of advanced stage. The pre-
served pattern of E-cadherin expression in the metastatic cells
seems inconsistent with an invasion metastasis-suppressor
role. Heterogeneity of tumours. with areas of preserved and
reduced expression. could potentially lead to an inaccurate
classification of some primary tumours. Cell-cell adhesion is
a complex process involving multiple protein interactions.
and other defects mav exist in cases where tumour cells
appear to invade or metastasise despite normal E-cadherin
protein expression. A cytosolic protein associated with E-
cadherin. a-catenin. has been shown to be critically impor-
tant in normal cadherin function (Hirano et al., 1992;
Shimoyama et al.. 1992). Reduced expression of a-catenin
protein was recently found to be correlated with invasion and
metastases in squamous cell cancer of the oesophagus (Kado-
waki et al., 1994). A homozygous deletion of the x-catenin
gene has been reported to occur in both a human bladder
and lung cancer cell line leading to the loss of expression of
a-catenin mRNA, protein and, significantly, a decrease in
calcium-dependent cell aggregation (Hirano et al., 1992;
Morton et al., 1993). In a fashion similar to transfections
studies with E-cadherin described earlier (Frixen et al., 1991;
Velminckx et al., 1991), transfection of m-catenin cDNA into
PC9 lung adenocarcinoma cell results in restored aggregation
properties (Hirano et al., 1992). The x-catenin gene is appar-
ently intact in the oesophageal adenocarcinoma metastases
examined here, as abundant mRNA for x-catenin was detect-
ed. These metastatic cells also express E-cadhenrn protein in a
preserved pattern (Figure lh and 1), which is known to be
necessary for normal x-catenin protein expression (Nagafuchi
et al., 1991). Alterations in E-cadhenrn protein expression,
however, may be transient, and affected by differing condi-
tions present in the primary tumour and the metastatic site.
The alteration might be at the level of E-cadherin transcrip-
tion, translation or post-translational processing of the
mature protein. A subset of cells within the primary tumour
might transiently lose E-cadherin expression, metastasise and
then re-express the protein at the distant site under different
and perhaps E-cadherin-inducing conditions (i.e. lymph nodes).
Alternatively, the observation that preserved E-cadherin pro-
tein expression is present at all metastatic sites examined may
support the hypothesis that some degree of cell-cell adhesion
is required for the formation of metastatic foci. Tumour cells
which adhere as a mass ofcells may have survival advantages
both in circulation and at the metastatic site.
The association of altered E-cadherin expression wAith
advanced stage in thoracic tumours is consistent with other
reports implicating loss of E-cadherin as being an important
factor in invasion and metastases in human malignancy.
Additionally. altered expression of E-cadherin in Barrett's
oesophagus provides important evidence that changes in cell
adhesion may be early events in tumorigenesis. Preserved
E-cadhenrn protein expression was observed in metaplastic
Barrett's mucosa. however dysplastic Barrett's oesophagus
demonstrated both reduced and disorganised E-cadherin pro-
tein expression patterns (Figure lc and d). A similar finding
of loss of E-cadherin expression in dysplastic Barrett's
oesophagus as compared with normal squamous and meta-
plastic Barrett's oesophagus has recently been reported (Jan-
kowski et al., 1994). Altered E-cadherin protein expression in
dysplastic Barrett's mucosa is probably associated with some
degree of altered cell adhesion and importantly is present in
tissues which may progress to adenocarcinoma but are not
yet invasive. This finding is very much in accord with
reported mutations within the APC gene present in premalig-
nant. adenomatous polyps of the colon (Rubinfield et al..
1993: Su et al.. 1993). The APC gene product is associated
with P-catenin and is probably involved in cell adhesion. The
interaction between E-cadherin and the actin cytoskeleton
probably has direct affects upon cell morphology. His-
tological descriptions of dysplasia or the state of
differentiation may be indirect descriptions of the state of cell
adhesion.
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